Application of machine learning methods to bridge the gap between non-interventional studies and randomized controlled trials in ophthalmic patients with neovascular age-related macular degeneration

Macular Degeneration ◽

Controlled Trials ◽

Learning Methods ◽

Randomized Controlled ◽

Machine Learning Methods ◽

PSS8 - IDENTIFYING THE CONFOUNDERS THAT EXPLAIN THE DIFFERENCE IN READOUTS BETWEEN NON-INTERVENTIONAL STUDIES (NIS) AND RANDOMIZED CONTROLLED TRIALS (RCTS): THE CASE OF TREATMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD)

Value in Health ◽

10.1016/j.jval.2018.09.2508 ◽

2018 ◽

Vol 21 ◽

pp. S423 ◽

Cited By ~ 1

Author(s):

A. Sagkriotis ◽

R. Griner ◽

A. Durus ◽

O.M. Doyle ◽

L. Rodriguez Torres ◽

...

Keyword(s):

Macular Degeneration ◽

Controlled Trials ◽

Randomized Controlled ◽

Age Related ◽

The Difference

Assessment of reporting quality of meta-analyses of randomized controlled trials in neovascular age-related macular degeneration published from April 2014 to May 2018 using prisma statement

International Ophthalmology ◽

10.1007/s10792-019-01282-7 ◽

2020 ◽

Vol 40 (5) ◽

pp. 1163-1180 ◽

Cited By ~ 1

Author(s):

Ourania Tounakaki ◽

Αngeliki Tsakou ◽

Angelakis Malamas ◽

Doxani Chrisoula ◽

Stefanidis Ioannis ◽

...

Keyword(s):

Macular Degeneration ◽

Reporting Quality ◽

Controlled Trials ◽

Randomized Controlled ◽

Age Related ◽

Prisma Statement ◽

Meta Analyses

Comparsion of efficacy and safety between conbercept and ranbizumab in neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials

Ophthalmic Research ◽

10.1159/000519815 ◽

2021 ◽

Author(s):

Xue Wang ◽

Chaofeng Yu ◽

Jiasong Yang ◽

Yuzhen Liu ◽

Yali Xu ◽

...

Keyword(s):

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age‑related macular degeneration: A meta‑analysis of randomized controlled trials

Experimental and Therapeutic Medicine ◽

10.3892/etm.2018.6305 ◽

2018 ◽

Author(s):

Qingquan Wei ◽

Junling Liu ◽

Qingyu Liu ◽

Chengda Ren ◽

Wenting Cai ◽

...

Keyword(s):

Photodynamic Therapy ◽

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Role of Lutein Supplementation in the Management of Age-Related Macular Degeneration: Meta-Analysis of Randomized Controlled Trials

Ophthalmic Research ◽

10.1159/000363327 ◽

2014 ◽

Vol 52 (4) ◽

pp. 198-205 ◽

Cited By ~ 17

Author(s):

Xin Wang ◽

Caihui Jiang ◽

Ying Zhang ◽

Yan Gong ◽

Xiaofei Chen ◽

...

Keyword(s):

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Comparative Efficacy and Safety of Different Therapeutic Regimens of Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration: A Network Meta-Analysis of Randomized Controlled Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3493218 ◽

2019 ◽

Author(s):

Xin-yu Zhao ◽

Er-qian Wang ◽

Sheng-zhi Liu ◽

An-yi Liang ◽

Ruo-an Han ◽

...

Keyword(s):

Macular Degeneration ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Management of neovascular Age-related macular degeneration: A review on landmark randomized controlled trials

Middle East African Journal of Ophthalmology ◽

10.4103/0974-9233.173133 ◽

2016 ◽

Vol 23 (1) ◽

pp. 27 ◽

Cited By ~ 12

Author(s):

Vishali Gupta ◽

Aniruddha Agarwal ◽

Kanika Aggarwal

Keyword(s):

Macular Degeneration ◽

Controlled Trials ◽

Randomized Controlled ◽

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials

BMC Ophthalmology ◽

10.1186/s12886-018-0785-3 ◽

2018 ◽

Vol 18 (1) ◽

Cited By ~ 14

Author(s):

Chu Luan Nguyen ◽

Lawrence J. Oh ◽

Eugene Wong ◽

Joe Wei ◽

Michael Chilov

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Meta Analysis ◽

Controlled Trials ◽

Vascular Endothelial ◽

Randomized Controlled ◽

Age Related ◽

Endothelial Growth Factor

Intravitreal Bevacizumab and Cardiovascular Risk in Patients with Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies

Drug Safety ◽

10.1007/s40264-016-0408-y ◽

2016 ◽

Vol 39 (6) ◽

pp. 517-541 ◽

Cited By ~ 13

Author(s):

Ivana Mikačić ◽

Damir Bosnar

Keyword(s):

Systematic Review ◽

Cardiovascular Risk ◽

Observational Studies ◽

Meta Analysis ◽

Intravitreal Bevacizumab ◽

Controlled Trials ◽

Randomized Controlled ◽

Comparative Efficacy and Safety of 37 Regimens of Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration: A Network Meta-Analysis of Randomized Controlled Trials

SSRN Electronic Journal ◽

10.2139/ssrn.3516129 ◽

2020 ◽

Author(s):

Xin-yu Zhao ◽

Er-qian Wang ◽

Sheng-zhi Liu ◽

Mingyue Luo ◽

Ruo-an Han ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Meta Analysis ◽

Controlled Trials ◽

Vascular Endothelial ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Age Related ◽

Endothelial Growth Factor